Multifocal motor neuropathy with conduction block that was shown by the flexor digitorum profundus muscle innervated from the ulnar nerve

Q4 Immunology and Microbiology
Kazuyuki Saito, Hiroaki Yokote, Shuta Toru
{"title":"Multifocal motor neuropathy with conduction block that was shown by the flexor digitorum profundus muscle innervated from the ulnar nerve","authors":"Kazuyuki Saito, Hiroaki Yokote, Shuta Toru","doi":"10.1111/cen3.12748","DOIUrl":null,"url":null,"abstract":"To the Editor, Multifocal motor neuropathy (MMN) is a rare immune-mediated neuropathy characterized by progressive asymmetric limb weakness with the expression of anti-GM1 immunoglobulin M (IgM) antibodies. Conduction block (CB) shown by nerve conduction studies (NCS) is the most important feature for its diagnosis. A 28-year-old Japanese woman presented with a week-long history of progressive right hand muscle weakness without any sensory dysfunction. Her grip strength was 12/25 kg (right/left), the muscle strength of both the abductor pollicis brevis and abductor digiti minimi was 5/5. That of both the wrist extensor and wrist flexor was 5/5 according to the Medical Research Council grade. Her tendon reflexes were normal in the upper and lower limbs. The Babinski sign was bilaterally negative. Routine NCS recorded from the abductor pollicis brevis (Figure 1a) and abductor digiti minimi (Figure 1b) was in the normal range (skin temperature was maintained at 32 C). A cerebrospinal fluid examination detected no cells and showed a normal protein concentration (22.3 mg/ dL). Serum immunoglobulin G (1603 mg/dL) and IgM (166 mg/dL) were within the normal range, and serum anti-nuclear antibodies were negative. Serological testing for anti-ganglioside antibodies were positive for anti-GM1 IgM (+) and anti-GalNAc-GD1a IgM (++) antibodies. We initially suspected MMN without CB. The patient was given a 5-day course of high-dose intravenous immunoglobulin (IVIG) therapy (0.4 g/kg/day). Her right grip strength improved to 25 kg (left 25 kg). Both the anti-GM1 IgM (+) and antiGalNAc-GD1a IgM (++) antibodies were still positive 8 weeks after the first IVIG therapy. After another 6 months, her right grip strength declined to 12 kg. The muscle strength of the flexor digitorum profundus (FDP) was 4/5 (right/left), although that of the abductor pollicis brevis, abductor digiti minimi, extensor carpi radialis longus, extensor carpi ulnaris, flexor carpi radialis, extensor digitorum communis, abductor pollicis longus, extensor pollicis brevis, extensor pollicis longus, flexor pollicis longus, wrist extensor and wrist flexor was 5/5 (right/left; Medical Research Council grade). We carried out NCS of the FDP muscle innervated from the ulnar nerve (Figure 1c), CB was shown by a 19.6% reduction in compound muscle action potentials (CMAP; 5.1 to 4.1 mV) and 33.5% reduction in the CMAP area (33.1 to 22.0 mVms) between 42 and 18 mm from the medial epicondyle with normal motor conduction velocities (Figure 1d,e; 42 to 18 mm from the medial epicondyle = 68.6 m/s). These electrophysiological findings fulfilled the European Federation of Neurological Societies' electrophysiological criteria for possible motor CB in MMN; we finally diagnosed her with MMN. IVIG therapy was effective and her right grip strength improved to 28 kg. One month after the second IVIG treatment, the CB improved to 6.5% (4.6 to 4.3 mV) for the CMAP and 9.9% for CMAP area (26.3 to 23.6 mVms) at the same distance as the previous examination in NCS recorded by FDP (Figure 1f,g). The titer of anti-GM1 IgM antibodies did not change (+), although the titer of anti-GalNAcGD1a IgM antibodies decreased to (+). After >3 years of maintenance IVIG treatment, we gradually extended the treatment interval of IVIG, then eventually discontinued. She had no recurrence for >8 years after her relapse. We described a Japanese woman with MMN who showed CB based on tests of the FDP muscle, and anti-GM1 IgM and anti-GalNAc-GD1a IgM antibody positivity. Initially, we could not prove CB with routine NCS. Although there are several reports about MMN without CB, it is undeniable that CB might not be fully proven in such cases. Muscle weakness is not always uniform for each muscle innervated by the same nerve in MMN. When MMN is suspected, it is important to identify the muscles that are selected in NCS. It is useful to examine the anti-ganglioside antibody assays in diagnosing MMN in which CB cannot be identified, because IVIG would be effective for such cases.","PeriodicalId":10193,"journal":{"name":"Clinical and Experimental Neuroimmunology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Neuroimmunology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cen3.12748","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0

Abstract

To the Editor, Multifocal motor neuropathy (MMN) is a rare immune-mediated neuropathy characterized by progressive asymmetric limb weakness with the expression of anti-GM1 immunoglobulin M (IgM) antibodies. Conduction block (CB) shown by nerve conduction studies (NCS) is the most important feature for its diagnosis. A 28-year-old Japanese woman presented with a week-long history of progressive right hand muscle weakness without any sensory dysfunction. Her grip strength was 12/25 kg (right/left), the muscle strength of both the abductor pollicis brevis and abductor digiti minimi was 5/5. That of both the wrist extensor and wrist flexor was 5/5 according to the Medical Research Council grade. Her tendon reflexes were normal in the upper and lower limbs. The Babinski sign was bilaterally negative. Routine NCS recorded from the abductor pollicis brevis (Figure 1a) and abductor digiti minimi (Figure 1b) was in the normal range (skin temperature was maintained at 32 C). A cerebrospinal fluid examination detected no cells and showed a normal protein concentration (22.3 mg/ dL). Serum immunoglobulin G (1603 mg/dL) and IgM (166 mg/dL) were within the normal range, and serum anti-nuclear antibodies were negative. Serological testing for anti-ganglioside antibodies were positive for anti-GM1 IgM (+) and anti-GalNAc-GD1a IgM (++) antibodies. We initially suspected MMN without CB. The patient was given a 5-day course of high-dose intravenous immunoglobulin (IVIG) therapy (0.4 g/kg/day). Her right grip strength improved to 25 kg (left 25 kg). Both the anti-GM1 IgM (+) and antiGalNAc-GD1a IgM (++) antibodies were still positive 8 weeks after the first IVIG therapy. After another 6 months, her right grip strength declined to 12 kg. The muscle strength of the flexor digitorum profundus (FDP) was 4/5 (right/left), although that of the abductor pollicis brevis, abductor digiti minimi, extensor carpi radialis longus, extensor carpi ulnaris, flexor carpi radialis, extensor digitorum communis, abductor pollicis longus, extensor pollicis brevis, extensor pollicis longus, flexor pollicis longus, wrist extensor and wrist flexor was 5/5 (right/left; Medical Research Council grade). We carried out NCS of the FDP muscle innervated from the ulnar nerve (Figure 1c), CB was shown by a 19.6% reduction in compound muscle action potentials (CMAP; 5.1 to 4.1 mV) and 33.5% reduction in the CMAP area (33.1 to 22.0 mVms) between 42 and 18 mm from the medial epicondyle with normal motor conduction velocities (Figure 1d,e; 42 to 18 mm from the medial epicondyle = 68.6 m/s). These electrophysiological findings fulfilled the European Federation of Neurological Societies' electrophysiological criteria for possible motor CB in MMN; we finally diagnosed her with MMN. IVIG therapy was effective and her right grip strength improved to 28 kg. One month after the second IVIG treatment, the CB improved to 6.5% (4.6 to 4.3 mV) for the CMAP and 9.9% for CMAP area (26.3 to 23.6 mVms) at the same distance as the previous examination in NCS recorded by FDP (Figure 1f,g). The titer of anti-GM1 IgM antibodies did not change (+), although the titer of anti-GalNAcGD1a IgM antibodies decreased to (+). After >3 years of maintenance IVIG treatment, we gradually extended the treatment interval of IVIG, then eventually discontinued. She had no recurrence for >8 years after her relapse. We described a Japanese woman with MMN who showed CB based on tests of the FDP muscle, and anti-GM1 IgM and anti-GalNAc-GD1a IgM antibody positivity. Initially, we could not prove CB with routine NCS. Although there are several reports about MMN without CB, it is undeniable that CB might not be fully proven in such cases. Muscle weakness is not always uniform for each muscle innervated by the same nerve in MMN. When MMN is suspected, it is important to identify the muscles that are selected in NCS. It is useful to examine the anti-ganglioside antibody assays in diagnosing MMN in which CB cannot be identified, because IVIG would be effective for such cases.
由尺神经支配的指深屈肌显示的多灶性运动神经病伴传导阻滞
编者按,多灶性运动神经病(MMN)是一种罕见的免疫介导的神经病,其特征是伴有抗GM1免疫球蛋白M(IgM)抗体表达的进行性不对称肢体无力。神经传导研究(NCS)显示的传导阻滞(CB)是其诊断的最重要特征。一名28岁的日本女性出现了为期一周的进行性右手肌无力病史,没有任何感觉功能障碍。她的握力为12/25公斤(右/左),拇短展肌和小指展肌的肌力均为5/5。根据医学研究委员会的评分,腕伸肌和腕屈肌的评分均为5/5。她的上下肢肌腱反射正常。巴宾斯基征双侧为阴性。从拇短展肌(图1a)和小指展肌(见图1b)记录的常规NCS在正常范围内(皮肤温度保持在32℃)。脑脊液检查未检测到细胞,并且显示正常的蛋白质浓度(22.3mg/dL)。血清免疫球蛋白G(1603mg/dL)和IgM(166mg/dL)在正常范围内,血清抗核抗体呈阴性。抗神经节苷脂抗体的血清学检测为抗GM1-IgM(+)和抗GalNAc-GD1a IgM(++)抗体阳性。我们最初怀疑MMN没有CB。患者接受为期5天的高剂量静脉注射免疫球蛋白(IVIG)治疗(0.4 g/kg/天)。她的右握力提高到25公斤(左25公斤)。抗GM1-IgM(+)和抗GalNAc-GD1a IgM(++)抗体在第一次IVIG治疗后8周仍呈阳性。又过了6个月,她的右握力下降到12公斤。指深屈肌(FDP)的肌肉力量为4/5(右/左),尽管拇展肌、小指展肌、桡侧腕长伸肌、尺侧腕伸肌、,拇长伸肌、拇长屈肌、腕伸肌和腕屈肌为5/5(右/左;医学研究委员会级别)。我们对尺神经支配的FDP肌肉进行了NCS(图1c),CB显示,在运动传导速度正常的情况下,复合肌肉动作电位(CMAP;5.1至4.1 mV)降低19.6%,距离内侧上髁42至18 mm的CMAP面积(33.1至22.0 mVms)降低33.5%(图1d,e;距离内侧上颚42至18毫米=68.6 m/s)。这些电生理学发现符合欧洲神经学会联合会关于MMN中可能的运动CB的电生理学标准;我们最终诊断她患有MMN。IVIG治疗有效,她的右握力提高到28公斤。第二次IVIG治疗一个月后,在与FDP记录的NCS先前检查相同的距离处,CMAP的CB提高到6.5%(4.6至4.3 mV),CMAP区域的CB提高了9.9%(26.3至23.6 mVms)(图1f,g)。抗-GM1 IgM抗体的滴度没有变化(+),尽管抗-GalNAcGD1a IgM抗体滴度降至(+)。经过3年以上的IVIG维持治疗,我们逐渐延长了IVIG的治疗间隔,然后最终停止。复发后8年以上没有复发。我们描述了一名患有MMN的日本女性,她根据FDP肌肉测试显示CB,抗GM1 IgM和抗GalNAc-GD1a IgM抗体阳性。最初,我们无法用常规NCS来证明CB。尽管有几篇关于没有CB的MMN的报道,但不可否认的是,CB在这种情况下可能没有得到充分证明。MMN中由同一神经支配的每一块肌肉的肌无力并不总是均匀的。当怀疑MMN时,识别NCS中选择的肌肉是很重要的。检查抗神经节苷脂抗体测定在诊断不能识别CB的MMN中是有用的,因为IVIG对这种情况有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical and Experimental Neuroimmunology
Clinical and Experimental Neuroimmunology Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
CiteScore
1.60
自引率
0.00%
发文量
52
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信